Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 101
Filter
Add more filters

Publication year range
1.
Br J Pharmacol ; 122(7): 1395-404, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9421287

ABSTRACT

1. Effects on the pinacidil-induced outward current of inhibitors of tyrosine kinases and phosphatases were investigated by use of a patch-clamp method in smooth muscle cells of the rabbit portal vein. 2. A specific tyrosine kinase inhibitor, genistein, inhibited the pinacidil-induced current in a concentration-dependent manner with an IC50 of 5.5 microM. Superfusion of Ca2+-free solution did not affect this inhibitory effect of genistein. At higher concentrations, genistein inhibited the voltage-dependent Ba2+ and K+ currents with IC50 values of > 100 microM and 75 microM respectively. Tyrphostin B46 (30 microM), a tyrosine kinase inhibitor, also inhibited the pinacidil-induced current by 70% of the control. 3. Sodium orthovanadate (100 microM), an inhibitor of tyrosine phosphatase, slightly but significantly enhanced both the pinacidil-induced and delayed rectifier K+ currents. Daidzein (100 microM), an inactive analogue of genistein, did not inhibit these currents. 4. Neither herbimycin A (1 microM), lavendustin A (30 microM), tyrphostin 23 (10 microM), which are also tyrosine kinase inhibitors, nor wortmannin (10 microM), a phosphatidylinositol 3-kinase inhibitor, had an effect on either the pinacidil-induced or delayed rectifier K+ currents. Epidermal growth factor (EGF; 1 microg ml(-1)) did not induce an outward current or enhance the pinacidil-induced current. 5. Pinacidil alone, in the cell-attached configuration, or pinacidil with GDP, in the inside-out configuration, activated a 42 pS channel in the smooth muscle cells of the rabbit portal vein. Genistein (30 microM) reduced the channel's open probability without inducing a change in unitary conductance at any holding potential (-30 to +20 mV). 6. In the inside-out configuration, genistein at 30 microM did not change the mean channel open time, but reduced the burst duration. At 100 microM genistein abolished channel opening. The inhibitory potencies with which 30 and 100 microM genistein acted on the unitary current of the ATP-sensitive K+ channel were similar to those seen in the whole-cell voltage-clamp configuration. 7. Although direct inhibitory actions of genistein on the ATP-sensitive K+ channels are not ruled out, our results suggest that a protein tyrosine kinase may play a role in the regulation of ATP-sensitive K+ channel activity in the rabbit portal vein.


Subject(s)
Enzyme Inhibitors/pharmacology , Genistein/pharmacology , Muscle, Smooth, Vascular/drug effects , Portal Vein/drug effects , Potassium Channels/drug effects , Potassium/metabolism , Protein-Tyrosine Kinases/metabolism , Animals , Barium/metabolism , Dose-Response Relationship, Drug , Guanidines/pharmacology , Isoflavones/pharmacology , Male , Muscle, Smooth, Vascular/enzymology , Pinacidil , Protein-Tyrosine Kinases/antagonists & inhibitors , Rabbits , Vanadates/pharmacology , Vasodilator Agents/pharmacology
2.
Br J Pharmacol ; 117(2): 351-9, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8789390

ABSTRACT

1. Effects of oestradiol on the electrical and mechanical properties of the rabbit basilar artery were investigated by use of microelectrode, patch-clamp and isometric tension recording methods. 2. Oestradiol (10 nM-100 microM) relaxed arterial tissue pre-contracted by excess [K]o solution (30 mM) in a concentration-dependent manner. In Ca-free solution, histamine (10 microM) and caffeine (20 mM) each produced a phasic contraction, but oestradiol (10 microM) did not significantly affect their amplitude. 3. Oestradiol (< or = 100 microM) did not change the resting membrane potential of the artery whether in the presence or absence of TEA (10 mM). Action potentials observed in the presence of 10 mM TEA were abolished by oestradiol (100 microM). 4. Oestradiol (1 microM-100 microM) inhibited the voltage-dependent Ba current in a concentration-dependent manner. Oestradiol (100 microM) inhibited the Ba current observed in the presence of nicardipine (1 microM) more than that in the absence of nicardipine (to 31.0% vs 62.0% of control). 5. GTP gamma S (30 microM) in the pipette enhanced the inhibitory actions of oestradiol on the Ba current. On the other hand, with GDP beta S (1 mM) in the pipette, oestradiol failed to inhibit the Ba current. Pertussis toxin (PTX 3 micrograms ml-1) in the pipette totally prevented the inhibitory action of oestradiol on the Ba current. 6. Oestradiol (< or = 100 microM) had no significant effect on the outward K currents evoked by a membrane depolarization. 7. These results strongly suggest that oestradiol relaxes arterial tissue by inhibition of voltage-dependent Ca channels and that it inhibits both nicardipine-sensitive and -resistant Ca currents via a PTX-sensitive GTP-binding protein. The main target of oestradiol among the arterial Ca channels seems to be the nicardipine-resistant Ca channel, rather than the nicardipine-sensitive one.


Subject(s)
Calcium Channel Blockers/pharmacology , Estradiol/pharmacology , GTP-Binding Proteins/physiology , Muscle, Smooth, Vascular/drug effects , Animals , Basilar Artery/cytology , Basilar Artery/drug effects , Female , Guanosine 5'-O-(3-Thiotriphosphate)/analogs & derivatives , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , In Vitro Techniques , Isometric Contraction/drug effects , Membrane Potentials/drug effects , Microelectrodes , Muscle Relaxation/drug effects , Muscle, Smooth, Vascular/cytology , Patch-Clamp Techniques , Potassium Channels/drug effects , Potassium Channels/metabolism , Rabbits
3.
Environ Health Perspect ; 108(6): 539-44, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10856028

ABSTRACT

We treated pregnant rats with 1 microg/kg body weight/day 1,2,3,4,6,7-hexachlorinated naphthalene (1,2,3,4,6,7-HxCN) on days 14-16 of gestation and examined the effects on the reproductive systems of their male offspring at various phases of sexual maturation. Sperm count in the cauda epididymidis did not change in 1,2,3,4,6, 7-HxCN-treated rats on postnatal day 89, the age of sexual maturity, but the sperm count in the cauda epididymidis did increase to approximately 180% of the control value on postnatal day 62. In addition, homogenization-resistant testicular spermatids increased to approximately 160% of the control value on postnatal day 48, and the percent of postmeiotic tubules increased to approximately 190% of the control value on postnatal day 31 in this group. These results indicate that the onset of spermatogenesis was accelerated in the 1,2,3,4,6,7-HxCN rats. Serum concentrations of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) had already reached the maximum level on postnatal day 31 in the 1,2,3,4,6, 7-HxCN group, suggesting that the onset of LH and FSH secretions from the pituitary gland was also accelerated and that this endocrine disruption was the cause of early onset of spermatogenesis in this group. In the fat of 1,2,3,4,6,7-HxCN-treated dams, 5.75+/-2.81 ppb 1,2,3,4,6,7-HxCN was detected when offspring were weaned. This concentration was 5-10 times higher than that found in human adipose tissue.


Subject(s)
Naphthalenes/adverse effects , Prenatal Exposure Delayed Effects , Sexual Maturation/drug effects , Spermatogenesis/drug effects , Adipose Tissue/chemistry , Animals , Female , Gonadotropins/pharmacology , Humans , Hydrocarbons, Chlorinated , Male , Naphthalenes/pharmacokinetics , Pregnancy , Rats , Rats, Wistar , Spermatogenesis/physiology , Time Factors , Tissue Distribution
4.
Int J Oncol ; 13(2): 297-303, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9664125

ABSTRACT

Carboxy-terminal telopeptide of type I collagen (ICTP) is a degradation product of type I collagen. In this study, we investigated the usefulness of measuring the serum ICTP concentration for diagnosing and monitoring bone metastasis from hepatocellular carcinoma (HCC). The serum concentrations of ICTP, type I procollagen carboxy-terminal propeptide (PICP), type III procollagen aminoterminal propeptide (PIIIP), type IV collagen (Ty IV), type IV collagen 7S-domain (7S), and hyaluronic acid (HA) were measured in patients with liver cirrhosis, HCC with or HCC without bone metastasis, and in healthy controls. The diagnostic efficiency of the serum ICTP and fibrosis marker levels in the HCC patients with and without bone metastasis was evaluated using receiver operating characteristic curves. We also retrospectively examined the changes in the serum ICTP levels before and after bone metastasis in the HCC patients. The serum ICTP level was significantly higher in the HCC patients with bone metastasis than in the patients with other diseases and the healthy controls. The serum PICP, PIIIP, Ty IV, 7S and HA levels of the HCC patients with bone metastasis did not differ significantly from those of the patients without bone metastasis. The diagnostic efficiency for HCC with bone metastasis was 87% for ICTP, 51% for PICP, 65% for Ty IV, 55% for PIIIP and 51% for HA. During the follow-up, the changes in the serum ICTP values paralleled the behavior of bone metastasis. These results indicate that the measurement of serum ICTP concentration is useful for detecting and monitoring HCC patients with bone metastasis.


Subject(s)
Bone Neoplasms/blood , Bone Neoplasms/secondary , Carcinoma, Hepatocellular/blood , Carcinoma, Hepatocellular/pathology , Collagen/blood , Liver Neoplasms/blood , Liver Neoplasms/pathology , Peptides/blood , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/biosynthesis , Bone Neoplasms/diagnosis , Collagen Type I , Female , Humans , Liver Cirrhosis/blood , Male , Middle Aged , Peptide Fragments/blood , Procollagen/blood , ROC Curve
5.
Int J Oncol ; 16(2): 375-82, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10639583

ABSTRACT

We evaluated the effects of angiogenesis inhibitor, TNP-470, on hepatocellular carcinoma (HCCs) induced by a choline-deficient L-amino acid defined (CDAA) diet in rats. Male Fisher 344 rats were fed CDAA for 68 weeks. Rats were treated by subcutaneous injection of TNP-470 (15 mg/kg) or saline (control) three times per week from 53 to 68 weeks. At the end of the experiment, we determined the frequency and size of HCCs and glutathione S-transferase placental form (GSTP)-positive lesions, histology of liver cirrhosis, liver function, and liver weight per body weight. We also determined, using histologic and immunohistochemical semiquantification analyses, the degree of vascularity, apoptosis and proliferation in HCC and adjacent tissues. Treatment with TNP-470 resulted in a reduction of the size and frequency of HCC compared to untreated rats. However, TNP-470 did not influence the histology of liver cirrhosis and liver function. The liver weight per body weight of TNP-470-treated rats was slightly heavier in comparison with that of the controls. Treatment with TNP-470 significantly reduced tumor vascularity relative to the controls. There were no significant differences in the Ki-67 labeling index of HCCs between TNP-470 treated and control rats. The frequency of apoptotic hepatoma cells in TNP-470-treated rats was higher than in control rats. Our results indicate that TNP-470 suppresses the progression of CDAA-induced HCCs in rats through inhibition of angiogenesis, and suggest that TNP-470 might be useful clinically for HCCs.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Carcinoma, Hepatocellular/drug therapy , Fatty Acids, Unsaturated/therapeutic use , Liver Neoplasms, Experimental/drug therapy , Sesquiterpenes/therapeutic use , Animals , Apoptosis/drug effects , Carcinoma, Hepatocellular/pathology , Choline/administration & dosage , Cyclohexanes , Diet , Liver Neoplasms, Experimental/pathology , Lung Neoplasms/secondary , Male , Neovascularization, Pathologic/drug therapy , O-(Chloroacetylcarbamoyl)fumagillol , Rats , Rats, Inbred F344
6.
Hum Pathol ; 30(4): 443-50, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10208467

ABSTRACT

Destruction of the extracellular matrices is required for tumor invasion and metastasis. Matrix metalloproteinase-2 degrades type IV collagen and laminin, major components of the basement membrane. Membrane type 1 matrix metalloproteinase activates the latent form of matrix metalloproteinase-2. We studied changes in membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 expression in relation to the tumor differentiation of hepatocellular carcinomas. Activity of matrix metalloproteinase-2 was also evaluated in hepatocellular carcinomas and noncancerous tissues. Overall, 37 hepatocellular carcinomas were studied. Expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 was determined by either immunohistochemistry (n=37) or in situ hybridization (n=6). Changes in membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 expression were evaluated in relation to tumor differentiation. Gelatinolytic activities were analyzed by gelatin zymography (n=4). Membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 were detected in hepatoma cells and stromal cells. In addition, these matrix metalloproteinases were detected in the same hepatoma cells. Increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 was associated with tumor dedifferentiation. The active form of matrix metalloproteinase-2 was more strongly expressed by hepatocellular carcinomas than by noncancerous tissues. These findings indicate that increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 was associated with tumor dedifferentiation, suggesting that these matrix metalloproteinases are intimately involved in the invasion of hepatocellular carcinomas.


Subject(s)
Carcinoma, Hepatocellular/enzymology , Collagenases/biosynthesis , Gelatinases/biosynthesis , Liver Neoplasms/enzymology , Metalloendopeptidases/biosynthesis , Adult , Aged , Aged, 80 and over , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/ultrastructure , Cell Differentiation , Female , Humans , Immunohistochemistry , In Situ Hybridization , Liver Neoplasms/pathology , Liver Neoplasms/ultrastructure , Male , Matrix Metalloproteinase 1 , Matrix Metalloproteinase 2 , Microscopy, Electron , Middle Aged
7.
Toxicol Sci ; 64(2): 224-32, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11719705

ABSTRACT

A 2-generation reproductive toxicity study of tributyltin chloride (TBTCl) was conducted in male rats using dietary concentrations of 5, 25, and 125 ppm TBTCl to evaluate its effect on sexual development and the reproductive system. F1 males were killed on postnatal day 119 and F2 males were killed on postnatal day 91. TBTCl affected the male reproductive system of rats. The weights of the testis and epididymis were decreased and homogenization-resistant spermatid and sperm count were reduced mainly in the 125 ppm TBTCl group. Histopathologic changes were also observed in the testis of this group and included vacuolization of the seminiferous epithelium, spermatid retention, and delayed spermiation. However, the changes were minimal in nature. The weight of the ventral prostate was decreased to 84% of the control value in the 125 ppm group in the F1 generation and decreased to 84 and 69% of the control value in the 25 ppm and 125 ppm TBTCl groups, respectively, in the F2 generation. The serum 17beta-estradiol concentration was also decreased to 55% of the control value in the 125 ppm group in the F1 generation and decreased to 78 and 57% of the control value in the 25 ppm and 125 ppm TBTCl groups, respectively, in the F2 generation. However, the serum concentrations of luteinizing hormone (LH) and testosterone were not decreased in these groups. These changes corresponded with those caused by aromatase inhibition and therefore TBTCl might be a weak aromatase inhibitor in male rats.


Subject(s)
Body Weight/drug effects , Testis/drug effects , Trialkyltin Compounds/toxicity , Animals , Crosses, Genetic , Dose-Response Relationship, Drug , Eating/drug effects , Epididymis/drug effects , Epididymis/growth & development , Estradiol/blood , Luteinizing Hormone/blood , Male , Organ Size/drug effects , Prostate/drug effects , Prostate/growth & development , Rats , Rats, Wistar , Reproduction/drug effects , Sex Characteristics , Sperm Count , Spermatids/drug effects , Spermatids/growth & development , Testis/pathology , Testosterone/blood , Trialkyltin Compounds/administration & dosage
8.
Neurosci Lett ; 304(1-2): 73-6, 2001 May 18.
Article in English | MEDLINE | ID: mdl-11335058

ABSTRACT

This study tested the effect of exposure to bisphenol A (BPA) early in life on the sexual differentiation in the brain and behavior in Wistar rats. We administered BPA only to mother rats during pregnancy and lactation at a dosage of approximately 1.5 mg/kg per day far less than the no-observed-adverse-effect level (NOAEL; 50 mg/kg per day). Control female offspring showed a higher activity, a lower avoidance memory, and larger locus coeruleus than the male controls, while the BPA-exposed group did not show any sexual dimorphism. BPA did not affect the reproductive organs or sex hormones. Our results suggest that the current methods to determine the NOAEL of artificial industrial chemicals may not be sufficient to detect a disruption of the sexual differentiation in the brain.


Subject(s)
Avoidance Learning/drug effects , Estrogens, Non-Steroidal/pharmacology , Locus Coeruleus/drug effects , Phenols/pharmacology , Prenatal Exposure Delayed Effects , Sex Differentiation/drug effects , Sexual Behavior, Animal/drug effects , Animals , Avoidance Learning/physiology , Benzhydryl Compounds , Female , Locus Coeruleus/physiology , Male , Pregnancy , Rats , Rats, Wistar , Sex Differentiation/physiology , Sexual Behavior, Animal/physiology
9.
J Gastroenterol ; 34(3): 405-9, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10433022

ABSTRACT

A 33-year-old woman with a history of photosensitivity, persistent abdominal pain, and liver dysfunction was admitted to our department because of abdominal pain and progression of liver dysfunction. On admission, levels of protoporphyrin and coproporphyrin within erythrocytes were markedly increased. Autofluorescent erythrocytes were also detected, leading to a diagnosis of erythropoietic protoporphyria. A liver biopsy specimen revealed cirrhosis with dark brown granules filling hepatocytes, bile canaliculi, and bile ductules. Transfusion of washed erythrocytes, hemodialysis, and administration of cholestyramine and beta-carotene transiently improved levels of porphyrins and liver function. The patient died of rupture of esophageal varices followed by multiple organ failure. However, the treatments were believed to have extended survival.


Subject(s)
Liver Cirrhosis/etiology , Liver Failure/etiology , Multiple Organ Failure/etiology , Porphyria, Hepatoerythropoietic/complications , Porphyria, Hepatoerythropoietic/therapy , Adult , Autopsy , Biopsy, Needle , Disease Progression , Drug Therapy, Combination , Esophageal and Gastric Varices/etiology , Fatal Outcome , Female , Humans , Liver Cirrhosis/pathology , Liver Cirrhosis/therapy , Liver Failure/pathology , Liver Function Tests , Porphyria, Hepatoerythropoietic/pathology , Renal Dialysis , Rupture, Spontaneous
10.
Brain Res Bull ; 8(4): 381-8, 1982 Apr.
Article in English | MEDLINE | ID: mdl-7093742

ABSTRACT

Age-related ultrastructural changes in the neuropil in the rat inferior olive nucleus were examined at 3, 6, 12, 18, 24 and 30 months old. The profiles of axon terminals, dendrites and astroglial processes from random samplings within the neuropil were traced. Subsequently, the percentages of these profiled areas in relation to the area of neuropil (relative volume fraction) were examined using the image analyzer system. The relative volume fractions of both axon terminals and dendrites in relation to the neuropil were found to have decreased in the aged rats, while the relative volume fraction of astroglial processes had progressively increased with aging.


Subject(s)
Olivary Nucleus/growth & development , Aging , Animals , Cytoplasmic Granules/ultrastructure , Male , Microscopy, Electron , Neurons/ultrastructure , Olivary Nucleus/ultrastructure , Rats , Rats, Inbred Strains
11.
Oncol Rep ; 7(6): 1293-8, 2000.
Article in English | MEDLINE | ID: mdl-11032932

ABSTRACT

Ultrasonography (US) and computed tomography (CT) are the most effective screening methodologies for hepatocellular carcinoma (HCC). In our US screening, 20% of small HCC nodules less than 20 mm in diameter were detected as hyperechoic tumors. Among these hyperechoic HCC nodules, we have often observed (BL) which is defined as hypoechoic nodules in the hyperechoic tumor. In this study, we report that the BL is a sign of dedifferentiation of early stage of HCC with fatty change by US. From 1994 to 1998, we performed tumor targeting needle biopsy in 938 hepatic nodular lesions. Among them, 284 nodules <20 mm in diameter, histologically diagnosed as HCC, were studied. BL is defined as a hyperechoic tumor containing a hypoechoic nodule >4 mm in diameter by US. Among 284 nodules, well, moderately and poorly differentiated HCC were 183 (64.4%), 100 (35.2%) and 1 (0.4%), respectively. On US, hypoechoic, isoechoic, and hyperechoic nodules were 188 (66.2%), 32 (11.3%) and 64 (22.5%), respectively. Forty-seven nodules of 64 hyperechoic HCC nodules <20 mm in diameter, 47 nodules (73.4%) showed fatty changes. Of 64 hyperechoic HCC nodules, we recognized 22 nodules (34.4%) as BL. The proportion of BL type hyperechoic nodules increased with the tumor size. Two hyperechoic nodules followed by US changed to BL with tumor enlargement. Histologic examination of a resected HCC with BL showed that hyperechoic HCC nodule represented well-differentiated HCC with fatty change and inner hypoechoic lesion represented moderately differentiated HCC without fatty change. In US screening for HCC, BL was often observed in HCC nodules from 11 to 20 mm in diameter. Histologic examination revealed that BL of HCC on US was associated with tumor progression and indicated dedifferentiation showing moderately differentiated HCC in well-differentiated HCC with fatty change.


Subject(s)
Carcinoma, Hepatocellular/diagnostic imaging , Liver Neoplasms/diagnostic imaging , Adult , Aged , Aged, 80 and over , Biopsy, Needle , Carcinoma, Hepatocellular/pathology , Cell Differentiation , Fatty Liver/diagnostic imaging , Fatty Liver/pathology , Female , Humans , Liver Neoplasms/pathology , Male , Middle Aged , Ultrasonography
12.
Oncol Rep ; 7(2): 249-56, 2000.
Article in English | MEDLINE | ID: mdl-10671666

ABSTRACT

To elucidate the risk factors for developing hepatocellular carcinoma (HCC) during the follow-up of patients with liver cirrhosis (LC), outpatients with LC were examined periodically by means of serum biochemical assessments, ultrasonography, and computed tomography. Risk factors for HCC were statistically analyzed. We also examined an efficacy of Lens culinaris agglutinin A-reactive profiles of alpha-fetoprotein (AFP-L3%) and des-gamma-carboxy prothrombin (DCP) value using a highly sensitive DCP determination kit (ED036) for the early recognition of HCC. The AFP-L3% and the ED036 value were retrospectively determined with stored serum samples. HCC was diagnosed in 21 of the 78 patients with LC during the follow-up period (mean follow-up period: 42 months). The estimated cumulative incidence of HCC was 25% with 3 years and 48% with 5 years. The most significant risk factor for the development of HCC in LC patients was found to be the mean serum AFP concentration from the year before the HCC detection (p=0.02). At the time of the recognition of HCC, the positive rates of the tumor markers were: serum AFP concentration 14%, serum DCP value 5%, AFP-L3% was 33%, and that of ED036 43%. The positive rate in collaborative use of AFP-L3% and ED036 was 67%. The simultaneous determination of the AFP-L3% and the ED036 value was shown to be effective for the early detection of HCC.


Subject(s)
Biomarkers, Tumor , Biomarkers , Carcinoma, Hepatocellular/diagnosis , Carcinoma, Hepatocellular/metabolism , Liver Cirrhosis/metabolism , Liver Neoplasms/diagnosis , Liver Neoplasms/metabolism , Protein Precursors/blood , Protein Precursors/metabolism , Prothrombin/metabolism , alpha-Fetoproteins/metabolism , Aged , Agglutinins , Carcinoma, Hepatocellular/etiology , Female , Follow-Up Studies , Humans , Liver Cirrhosis/complications , Liver Neoplasms/etiology , Male , Middle Aged , Predictive Value of Tests
13.
Int J Mol Med ; 3(5): 497-503, 1999 May.
Article in English | MEDLINE | ID: mdl-10202181

ABSTRACT

Kupffer cells are major matrix metalloproteinase-producing cells in the liver. The production of metalloproteinases in Kupffer cells may contribute to the improvement of liver fibrosis inducing liver cirrhosis. In this study, we examined the effect of the OK-432 (a biological response modifier) on the dimethylnitrosamine-induced liver cirrhosis in rats. Dimethylnitrosamine (10 microg/ml) was injected intraperitoneally into 20 male Wistar rats 3x/week for 4 weeks. For the subsequent 4 weeks, the animals were injected with saline (1 ml, 1x/week) (Group I, n=10) or OK-432 (1 Klinishe Einheit, 1x/week) (Group II, n=10). The control rats were injected with 1 ml saline for the initial 4 weeks and subsequent 4 weeks (Group III, n=10). The degree of hepatic fibrosis, the immunolocalization of type IV collagen, hyaluronic acid, and alpha-smooth muscle actin, and the mRNA expression by Northern blotting and the activity by gelatin zymography of metalloproteinase-9 were evaluated. Serum aminotransferase, hyaluronic acid, interleukin-1beta and tumor necrosis factor-alpha levels were measured. The deposition of á-smooth muscle actin and extracellular matrix containing type IV collagen and hyaluronic acid was markedly suppressed by OK-432. The mRNA expression and the activity of metalloproteinase-9 were markedly increased by OK-432. The serum aminotransferase and hyaluronic acid levels were decreased by OK-432. The serum interleukin-1 and tumor necrosis factor-alpha values were lower than the detectable limit in all samples from all three groups. These results indicate that OK-432 increased the production of metalloproteinase-9 and improved the rat dimethylnitrosamine-induced liver cirrhosis. OK-432 is suggested to be useful for the treatment of liver cirrhosis.


Subject(s)
Collagenases/biosynthesis , Immunologic Factors/pharmacology , Liver Cirrhosis, Experimental/drug therapy , Liver Cirrhosis, Experimental/metabolism , Picibanil/pharmacology , Actins/metabolism , Animals , Collagen/metabolism , Collagenases/genetics , Dimethylnitrosamine/toxicity , Hyaluronic Acid/metabolism , Immunohistochemistry , Liver Cirrhosis, Experimental/chemically induced , Male , Matrix Metalloproteinase 9 , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar
14.
J Toxicol Environ Health A ; 63(2): 127-44, 2001 May 25.
Article in English | MEDLINE | ID: mdl-11393799

ABSTRACT

A two-generation reproductive toxicity study of the effects of tributyltin chloride (TBTCl) was conducted in female rats using dietary concentrations of 5, 25, and 125 ppm TBTCl. Reproductive outcomes of dams (number and body weight of pups and the percentage of live pups) and the growth of female pups (the day of eye opening and body weight gain) were significantly decreased in the 125 ppm TBTCl group. A delay in vaginal opening and impaired estrous cyclicity were also observed in the 125 ppm TBTCl group. However, an increase in anogenital distance was found in all TBTCl groups on postnatal d 1. A dose-effect relationship was observed in TBTCl-induced changes in anogenital distance. These results indicate that the whole-life exposure to TBTCl affects the sexual development and reproductive function of female rats. In addition, the TBTCl-induced increase in anogenital distance seems to suggest it may exert a masculinizing effect on female neonates. However, the concentrations of TBTCl used in this study are not environmentally relevant.


Subject(s)
Genitalia, Female/drug effects , Prenatal Exposure Delayed Effects , Reproduction/drug effects , Sexual Maturation/drug effects , Trialkyltin Compounds/toxicity , Analysis of Variance , Animals , Animals, Newborn/growth & development , Biometry , Estradiol/blood , Estrus/drug effects , Female , Genitalia, Female/growth & development , Genitalia, Female/pathology , Growth/drug effects , Linear Models , Pregnancy , Random Allocation , Rats , Rats, Wistar , Testosterone/blood
15.
Int J Gynaecol Obstet ; 60(1): 41-6, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9506413

ABSTRACT

OBJECTIVE: The effects of conjugated equine estrogen (CEE) on bone mineral density (BMD) and biochemical indices of bone remodeling in oophorectomized women were studied for 3 years during estrogen replacement therapy (ERT) to investigate whether 0.625 mg/day of CEE alone prevent acute bone loss in the early stage of surgical menopause. METHODS: We divided the subjects into three groups according to interval between oophorectomy and the start of ERT (group 1: less than 2 years after surgery, n = 31; group 2: 2-5 years after surgery, n = 29; and group 3: more than 5 years after surgery, n = 27). Vertebral BMD was measured using dual energy X-ray absorptiometry (DEXA). Two biochemical indices of bone metabolism, urinary deoxypyridinoline (DPyr) and serum intact human osteocalcin (hOC) were also measured. RESULTS: In group 1, continuous ERT with 0.625 mg/day of CEE could not prevent a BMD decrease within the first year. However, by the end of the second year, BMD was restored to the pre-ERT. The same dosage of CEE significantly increased BMD in groups 2 and 3 by the end of the first year. DPyr and hOC levels both decreased dramatically in the initial 6 months of therapy and were stable thereafter. CONCLUSION: In the initial 2-year period after oophorectomy, 0.625 mg/day of CEE alone could not prevent acute bone loss suggesting that additional therapy for the prevention of osteoporosis may be needed.


Subject(s)
Bone Density/drug effects , Bone and Bones/metabolism , Estrogen Replacement Therapy , Estrogens, Conjugated (USP)/therapeutic use , Osteoporosis, Postmenopausal/prevention & control , Ovariectomy , Absorptiometry, Photon , Adult , Analysis of Variance , Bone and Bones/drug effects , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Humans , Middle Aged , Osteoporosis, Postmenopausal/etiology , Ovariectomy/adverse effects , Time Factors , Treatment Outcome
16.
Int J Gynaecol Obstet ; 62(1): 69-75, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9722129

ABSTRACT

OBJECTIVE: We previously reported that 0.625 mg/day of conjugated equine estrogen (CEE) could not prevent acute bone loss in the first year after oophorectomy. The effect of additional administration of ipriflavone on bone mineral density (BMD) and biochemical indices of bone remodeling were studied to investigate whether concurrent use of CEE and ipriflavone prevent acute bone loss in the early stages following surgical menopause. METHODS: One-hundred and sixteen oophorectomized women were randomly divided into four groups according to treatment; group 1: placebo, n = 30; group 2: CEE (0.625 mg/day), n = 29; group 3: ipriflavone (600 mg/day), n = 30; group 4: CEE (0.625 mg/day) plus ipriflavone (600 mg/day), n = 27. Vertebral BMD was measured using dual energy X-ray absorptiometry (DEXA) and two biochemical indices of bone metabolism, urinary pyridinoline (Pyr) and serum intact human osteocalcin (hOC), were also measured before, 24 weeks, and 48 weeks after initiation of treatment. RESULTS: BMD was reduced 48 weeks after treatment by 6.1, 3.9 and 5.1% in groups 1-3, respectively, but by only 1.2% in group 4. Pyr decreased by 49.5, 32.0 and 41.5% in groups 2-4, respectively. hOC also decreased by 45.2 and 21.6% in groups 2 and 4, but increased by 40.5% in group 3, suggesting an inhibitory action of CEE and ipriflavone on the turnover of bone metabolism and stimulatory action of ipriflavone on bone formation. CONCLUSION: Concomitant use of ipriflavone with CEE from an early stage after oophorectomy inhibited bone loss and was considered to be effective in maintaining bone mass after oophorectomy.


Subject(s)
Analgesics , Estrogens, Conjugated (USP)/therapeutic use , Isoflavones/therapeutic use , Osteoporosis/prevention & control , Ovariectomy , Absorptiometry, Photon , Adult , Amino Acids/urine , Bone Density/drug effects , Bone Remodeling/drug effects , Drug Therapy, Combination , Female , Humans , Middle Aged , Osteocalcin/urine
17.
Kurume Med J ; 45(1): 11-20, 1998.
Article in English | MEDLINE | ID: mdl-9658745

ABSTRACT

Type IV collagen and laminin, major components of the basement membrane, are involved in several biologic activities. In malignant tumors, cell-matrix interactions are very important for tumor invasion and metastasis. In hepatocellular carcinoma, these matrices are present around hepatoma cells. However, there is little known how these matrices influence on the behavior of hepatoma cells. In this study, we investigated the participation of type IV collagen and laminin in the motility, adhesion, and proliferation of hepatoma cells using three different human hepatoma cell lines (KYN-1, 2, 3). The production of type IV collagen and laminin was investigated by immunoelectron microscopy. The effects of type IV collagen and laminin on hepatoma cell migration, adhesion, and proliferation were evaluated by the haptotactic migration assay, phagokinetic track assay, an adhesion assay, and a 3H-thymidine incorporation assay. Immunoelectron microscopy showed the production of type IV collagen and laminin by hepatoma cells. Type IV collagen and laminin enhanced haptotactic migration, chemokinesis, adhesion, and thymidine incorporation by hepatoma cells. The combination of type IV collagen and laminin had the most pronounced effects on these biologic activities. These results indicate that type IV collagen and laminin promote hepatoma cell motility, adhesion, and proliferation in an autocrine manner, suggesting enhancement of invasion and metastasis of hepatoma cells by these basement membrane components in vivo.


Subject(s)
Carcinoma, Hepatocellular/physiopathology , Cell Movement/physiology , Collagen/physiology , Laminin/physiology , Liver Neoplasms/physiopathology , Neoplasm Proteins/physiology , Carcinoma, Hepatocellular/pathology , Cell Adhesion/physiology , Cell Division/physiology , Humans , Liver Neoplasms/pathology , Tumor Cells, Cultured
18.
Masui ; 39(1): 106-10, 1990 Jan.
Article in Japanese | MEDLINE | ID: mdl-2304244

ABSTRACT

A 72-year-old man, 154 cm tall, weighing 53 kg was suffering from severe herpetic neuralgia on his left 10th intercostal nerve area. His pain continued even he was treated with frequent epidural nerve block (4 to 5 times per week) by an anesthesiologist. He was referred to our hospital on his 105th pain day. He complained severe continuous pain and numbness on his left 10th intercostal nerve area. Touching the painful skin induced lightning pain. His pain was so severe that his sleeping was disturbed and also he could not maintain his usual life. Epidural nerve block at 10th thoracic nerve was done with 20mg methylprednisolone acetate and 5ml of 1% lidocaine. After the treatment, his pain was reduced to 3/10 of the one he had on admission, and also his sleep was not disturbed further. Epidural nerve blocks with methylprednisolone weekly for a month induced no more remission. At his 154th pain day, a dose of 20mg methyl prednisolone acetate and 1% lidocaine 5ml was given intrathecally through 2nd lumber intervertebral space. The pain was relieved completely after the block. And he complained nothing about the skin area which had been disturbing his life for a long time. Auditory brainstem response which was recorded during the block showed prolongation of the latency of phase III and phase V at 40 minutes after the intrathecal injection of lidocaine.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Herpes Zoster/complications , Methylprednisolone/analogs & derivatives , Neuralgia/drug therapy , Pain, Intractable/drug therapy , Aged , Anti-Inflammatory Agents/administration & dosage , Humans , Male , Methylprednisolone/administration & dosage , Methylprednisolone/therapeutic use , Methylprednisolone Acetate , Neuralgia/etiology , Pain, Intractable/etiology
19.
Masui ; 40(3): 500-5, 1991 Mar.
Article in Japanese | MEDLINE | ID: mdl-2072506

ABSTRACT

A 73-year-old man complained of pain in his right ear with vesicular lesion for three days. He complained of no weakness of facial musculatures, but muscle test revealed slight weakness in orbital and oral muscles on admission. His hearing acuity of the left ear was intact. Vertigo with spontaneous nystagmus to left was complained. The patient was treated with stellate ganglion block four times a day, prednisolone 80 mg a day p.o. and acyclovir i.v. Mannitol solution 300 ml a day for eight days was given i.v. to reduce edema and to protect facial nerve. On his 3rd hospital day, his paralysis progressed and he could not close his eye or whistle with his mouth. Evoked myogram showed 91% impairment of the nerve. During recovery period there was discrepancy between facial palsy score of clinical signs and degree of nerve impairment by evoked myogram. On his 12th hospital day his facial nerve score improved 9 to 12 (0 complete paralysis, 40 no paralysis) but evoked myogram showed further progress of nerve impairment from 86% to 91% (Evoked wave heights were 14% and 9% of normal site respectively). The discrepancy is probably because facial palsy score reflects also neurapraxia of inflammatory nerve, and stellate ganglion block has no effect on changing course of facial nerve injury.


Subject(s)
Autonomic Nerve Block , Facial Paralysis/prevention & control , Myoclonic Cerebellar Dyssynergia/complications , Stellate Ganglion , Aged , Facial Paralysis/etiology , Facial Paralysis/pathology , Humans , Male
20.
Nihon Rinsho ; 56(4): 956-60, 1998 Apr.
Article in Japanese | MEDLINE | ID: mdl-9577616

ABSTRACT

Contrast-enhanced ultrasonography (arterial infusion) has been clinically established as a qualitative diagnosis imaging tool for hepatocellular carcinoma (HCC). Contrast-enhanced ultrasonography (CEUS) was performed after of Albunex (sonicated serum albumin) or Carbon Dioxide (CO2) microbubble by hand, into the hepatic artery as a diagnostic modality for the early HCC. Here, we discussed the diagnosis of the early HCC by CEUS using Albunex as a contrast medium. Briefly, a diagnosis of the early HCC was made CEUS examination of the hemodynamics of the arteries showed a hypovascular pattern. And tumor size was under 20 mm in diameter, the histopathologic examination was essential to reach a final diagnosis, well-differentiated HCC.


Subject(s)
Albumins/administration & dosage , Carcinoma, Hepatocellular/diagnostic imaging , Contrast Media/administration & dosage , Liver Neoplasms/diagnostic imaging , Carcinoma, Hepatocellular/blood supply , Humans , Infusions, Intra-Arterial , Liver Neoplasms/blood supply , Microspheres , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL